Currently out of the existing stock ratings of Jamie Perse, 47 are a BUY (68.12%), 16 are a HOLD (23.19%), 6 are a SELL (8.7%).

Jamie Perse

Work Performance Price Targets & Ratings Chart

Analyst Jamie Perse, currently employed at GOLDMAN SACHS, has had 82.25% of price targets met with an average potential upside of 33.22%, reached in 241 days on average.

Jamie Perse has documented 132 price targets and ratings displayed on 11 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on AGL, agilon health at 07-May-2025.

Wall Street Analyst Jamie Perse

Analyst best performing recommendations are on APR (APRIA).
The best stock recommendation documented was for EHAB (ENHABIT) on 7/17/2023. The price target of $13 was fulfilled within 2 days with a profit of $0.36 (2.85%), with a performance score of 14.24.

Average potential price target upside

LFST Lifestance Health Group AGL agilon health APR Apria BTSG BrightSpring Health Services HCA HCA Holdings INNV InnovAge Holding Corp OPCH Option Care Health OSH Oak Street Health THC Tenet Healthcare UHS Universal Health Services EHAB Enhabit

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 09-Nov-2021

$9

$1.35 (17.65%)

$8

6 months 2 days ago
(14-May-2026)

3/6 (50%)

$1.11 (14.07%)

211

Buy Since 25-Jul-2025

$12

$4.35 (56.86%)

$11

6 months 8 days ago
(08-May-2026)

1/4 (25%)

$4.3 (55.84%)

286

Buy Since 23-Sep-2025

$12

$4.35 (56.86%)

$10

8 months 21 days ago
(25-Feb-2026)

4/9 (44.44%)

$5.04 (72.41%)

119

Buy Since 03-Apr-2025

$10

$2.35 (30.72%)

$8

8 months 21 days ago
(25-Feb-2026)

1/2 (50%)

$3.04 (43.68%)

399

Sell Since 09-Aug-2024

$7

$6

2 years 5 days ago
(10-Nov-2024)

2/2 (100%)

$-0.39 (-5.28%)

67

Show more analysts

Please expand the browser size to see the chart

What Year was the first public recommendation made by Jamie Perse?

On 2020
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?